logo
Salud por Derecho
Eng
  • Esp
  • Eng
logo
  • ABOUT US
  • WHAT WE DO
  • COLLABORATE
  • NEWS
Imagen destacada
Home Slider
We hope that the Government complies with the ruling and hears the company’s claims
01/07/2020 by Salud in Home Slider

In October 2019, the pharmaceutical company Novartis took legal action to attempt to prevent the Ministry of Health from publicly releasing the therapeutic and financial criteria justifying the approval and pricing of Kymriah, a new treatment within cellular immunotherapies (CART). The treatment for acute lymphoblastic leukaemia, a type of cancer of the bone marrow and the blood that especially affects children and those under 25, was priced at around 320,000 euros in Spain. It is the first treatment of its kind to be approved in Spain.

Now the judge, in the ruling just made public, has argued that the Ministry must hear the company to find out its claims. The judge pointed to a formal defect in the process and has urged the Ministry to step back and provide Novartis with a hearing before accepting or rejecting the request of the No es Sano campaign.

The campaign celebrates the fact that the judge has not opted in favour of preventing access to the information, as the company requested on the grounds of protecting its commercial interests, pointing to a formal defect in the process. The campaign also hopes that the Ministry of Health complies with the ruling and, having heard Novartis, continues the process of publication of the information requested.

The organizations that make up the campaign reiterate that it is fundamental to continue to take steps towards transparency and that his type of information in relation to the approval and financing of medicines and treatments must be considered to be of public interest, and therefore should be available to citizens. The Transparency Council itself has recognised this, as have international bodies such as the World Health Organization.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
Salud

Search

Subscribe to Newsletter

Estoy de acuerdo con la Política de privacidad.

LOCATION

Salud por Derecho
Duque Fernán Núñez, 2.
28012 Madrid
saludporderecho@saludporderecho.org

facebook twitter youtube

ABOUT US

About us

What we do

Collaborate

News

Privacy Policy

Cookie Policy

Publications

Press Area

SUBSCRIBE TO OUR NEWSLETTER

Estoy de acuerdo con la Política de privacidad.

Compartir:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
Share on email
Email
Share on whatsapp
Whatsapp
logo
Política de Cookies
Esta web utiliza cookies propias y de terceros para analizar tu navegación y ofrecerte un servicio más personalizado acorde a tus intereses. Continuar navegando implica la aceptación de nuestra Política de Cookies. También hemos actualizado nuestra Política de Privacidad para adecuarnos a la nueva normativa europea, puedes consultarla en la web. Aceptar Rechazar
Política de Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT